Visit Neuronet to learn about the various research projects launched by the Innovative Medicines Initiative (IMI), Europe’s biggest public and private collaboration in life sciences, aiming to better understand and develop treatments for neurological conditions, including Parkinson’s.
PD-MitoQUANT researchers have participated in Neuronet conference sessions and engaged with the Neuronet consortium through their popular social media campaigns. Here are a few examples of our Neuronet engagement activities.
At the April 7th, 2022 Parkinson’s Research in Ireland online event, Lewis Killin of SYNAPSE Research Management Partners spoke about the IMI2-funded Neuronet project (https://www.imi-neuronet.org/) and the role of public-private partnerships in research for neurodegenerative diseases.

Postdoc Hannah Scheiblich was interviewed by the Neuronet project on October 13th, 2021. Dr Scheiblich who is based at the German Center for Neurodegenerative Diseases and the Clinic for Neurodegenerative Diseases/Neurology at the University Hospital in Bonn, Germany discusses her career, research and the challenges and opportunities existing in her field. Read the interview here.

Dr Shruti Desai, Radboud University Nijmegen Medical Centre will present PD-MitoQUANT research at the 2021 Neuronet public event as part of the 31st Alzheimer Europe conference. Dr Desai’s talk is entitled: PD-MitoQUANT: QUANTIFICATION OF MITOCHONDRIAL MORPHOFUNCTION IN NEURONAL CELLS.

PD-MitoQUANT Coordinator Prof Jochen Prehn, of the RCSI, participated in a Neuronet roundtable session titled: “Public-private partnerships in the post-COVID era” at the Alzheimer Europe Conference 2020 on October 22, 2020. Read the full story.

On September 24, 2020, Dr Shruti Desai, a postdoc at Radboud University Nijmegen Medical Center within the Radboud Center for Mitochondrial Medicine (RCMM) responded to questions about her work as part of Neuronet’s series of interviews where they highlighted early-career investigators. Find the engaging interview here.

As part of Neuronet’s #WeAreNeuronet campaign to celebrate the great people behind the projects, Dr Orla Watters, a member of the PD-MitoQUANT research team at the RCSI (Royal College of Surgeons Ireland) featured on August 25, 2020.

Continuing the #WeAreNeuronet campaign to celebrate IMI projects and the great people behind them, Dana Bar-On, PD-MitoQUANT EFPIA Project Leader and Director of Teva Pharmaceutical Industries Ltd‘s Global R & D Academic Affairs featured.
Created for the #UniteforParkinsons campaign, this video showcases PD-MitoQUANT‘s quantitative approach to the characterisation of mitochondrial dysfunction in Parkinson’s disease.